Uveal melanoma
Uveal melanoma is the most common primary intraocular malignancy in adults. It is associated with a high rate of distant tumor spread and consequent mortality. Unlike retinoblastoma, for which treatment advances over the last few decades have resulted in a dramatic improvement in survival, outcomes for uveal melanoma patients remain unchanged. Despite improvement in local control of this tumor, roughly 50% of patients develop metastatic disease within 15 years. Delays in diagnosis and marked vascularity of this tumor may underlie that situation.
Source: Seminars in Diagnostic Pathology - Category: Pathology Authors: Seema Kashyap, Rachna Meel, Lata Singh, Mithalesh Singh Source Type: research
More News: Cancer & Oncology | Eye Cancers | Melanoma | Pathology | Retinoblastoma | Skin Cancer | Uveal Melanoma